{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["e1e1f7a5-e8e2-474d-b88d-62cf6ea43cd2", "Q1", 4380, "ASHLAND INC (PREVIOUSLY KNOWN AS ASHLAND LLC)", 104820, "ASHLAND INC (PREVIOUSLY KNOWN AS ASHLAND LLC)", 2013, "first_quarter", "2013-04-08T16:25:59.637000-04:00", 75000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/e1e1f7a5-e8e2-474d-b88d-62cf6ea43cd2/\", \"filing_uuid\": \"e1e1f7a5-e8e2-474d-b88d-62cf6ea43cd2\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2013, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/e1e1f7a5-e8e2-474d-b88d-62cf6ea43cd2/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": \"75000.00\", \"expenses_method\": \"a\", \"expenses_method_display\": \"Method A - Reporting amounts using LDA definitions only\", \"posted_by_name\": \"Charles F. Wilkinson, Senior Corporate Counsel\", \"dt_posted\": \"2013-04-08T16:25:59.637000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"50 East RiverCenter Boulevard\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Covington\", \"registrant_state\": \"KY\", \"registrant_zip\": \"41011\", \"registrant\": {\"id\": 4380, \"url\": \"https://lda.senate.gov/api/v1/registrants/4380/\", \"house_registrant_id\": 31245, \"name\": \"ASHLAND INC (PREVIOUSLY KNOWN AS ASHLAND LLC)\", \"description\": \"Specialty Chemicals\", \"address_1\": \"50 East RiverCenter Boulevard\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"Covington\", \"state\": \"KY\", \"state_display\": \"Kentucky\", \"zip\": \"41011\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"KEVIN HIGGINS\", \"contact_telephone\": \"+1 614-790-2101\", \"dt_updated\": \"2026-01-06T22:51:04.298782-05:00\"}, \"client\": {\"id\": 104820, \"url\": \"https://lda.senate.gov/api/v1/clients/104820/\", \"client_id\": 12, \"name\": \"ASHLAND INC (PREVIOUSLY KNOWN AS ASHLAND LLC)\", \"general_description\": \"Specialty Chemicals\", \"client_government_entity\": false, \"client_self_select\": true, \"state\": \"KY\", \"state_display\": \"Kentucky\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"KY\", \"ppb_state_display\": \"Kentucky\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2020-01-01\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Escolol S.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 49008, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"JOHN\", \"nickname\": null, \"middle_name\": \"S\", \"last_name\": \"RILEY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"ENV\", \"general_issue_code_display\": \"Environment/Superfund\", \"description\": \"Funding for NAS study of styrene; chemical security; superfund tax.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 49008, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"JOHN\", \"nickname\": null, \"middle_name\": \"S\", \"last_name\": \"RILEY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"TAR\", \"general_issue_code_display\": \"Tariff (miscellaneous tariff bills)\", \"description\": \"HR 5759\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 49008, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"JOHN\", \"nickname\": null, \"middle_name\": \"S\", \"last_name\": \"RILEY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"TAX\", \"general_issue_code_display\": \"Taxation/Internal Revenue Code\", \"description\": \"Corporate tax policy.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 49008, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"JOHN\", \"nickname\": null, \"middle_name\": \"S\", \"last_name\": \"RILEY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["e1e1f7a5-e8e2-474d-b88d-62cf6ea43cd2"], "units": {}, "query_ms": 41.61986097460613, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}